Bonnie Lacroix

Title: Innovator Spotlight: Bonnie Lacroix

Introduction

Bonnie Lacroix is an accomplished inventor based in Durham, NC. With an impressive portfolio of three patents, she has made significant contributions to the field of cancer research. Her work primarily focuses on developing innovative solutions for cancer treatment, particularly through the use of splice-switching oligonucleotides.

Latest Patents

Bonnie's latest patents include two notable inventions centered around splice-switching oligonucleotides. The first patent details methods and compositions aimed at treating cancer by downregulating the expression of AR or EGFR. The second patent is specifically geared towards treating castrate-resistant prostate cancer by employing splice-switching oligonucleotides to target AR expression. These groundbreaking inventions have the potential to enhance treatment options for patients battling various forms of cancer.

Career Highlights

Currently, Bonnie Lacroix is affiliated with Duke University, where she actively engages in cancer research. Her educational background and professional expertise have positioned her as a key player in the ongoing quest for innovative cancer therapies. Her commitment to research and improvement in patient care illustrates her dedication to making a meaningful impact in the medical field.

Collaborations

In her career, Bonnie has collaborated with esteemed colleagues, including Jennifer Freedman and Brendon Patierno. These partnerships foster an environment of innovation and discovery, merging diverse expertise to advance cancer research and develop effective treatments.

Conclusion

Bonnie Lacroix stands out as an influential inventor in cancer research, exemplifying how innovative thinking can lead to significant advancements in medical treatments. Her dedicated work and recent inventions highlight her commitment to making a difference in the fight against cancer, while her collaborations continue to inspire and propel the field forward.